Chengdu Kanghua Biological Products Co., Ltd. (SHE:300841)

China flag China · Delayed Price · Currency is CNY
48.31
+1.72 (3.69%)
Jul 15, 2026, 3:04 PM CST
Market Cap6.05B -23.2%
Revenue (ttm)1.20B -4.7%
Net Income226.55M -16.1%
EPS1.74 -15.5%
Shares Out 129.95M
PE Ratio26.72
Forward PE22.40
Dividend0.50 (1.09%)
Ex-Dividend DateMay 29, 2026
Volume3,417,502
Open44.79
Previous Close46.59
Day's Range44.79 - 48.80
52-Week Range43.25 - 94.30
Beta0.44
Analystsn/a
Price Targetn/a
Earnings DateAug 18, 2026

About SHE:300841

Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, and operation of biological products in China. It offers freeze-dried human rabies vaccines; ACYW135 meningococcal polysaccharide vaccine. The company was founded in 2004 and is based in Chengdu, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 550
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300841
Full Company Profile

Financial Performance

In 2025, SHE:300841's revenue was 1.17 billion, a decrease of -18.64% compared to the previous year's 1.43 billion. Earnings were 219.90 million, a decrease of -44.84%.

Financial Statements